UPDATE: Veridex, Mass General to Develop Platform for Circulating Tumor Cells

The partners will develop a bench-top platform to isolate and explore the biology of rare cells at the protein, RNA, and DNA levels.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.